Kemiko - successful enterprise

This project aims to produce two medicinal products - aspirin and paracetamol under its own brand name. It is planned to implement the following activities within the project: 1. Activity for realization of the entrepreneurial idea market, which includes the following sub-actions: 1.1. Purchase of specific technological equipment to ensure the production process. 1.2. Purchase of materials and consumables for direct use in production. 1.3. Hiring qualified staff needed to realize the entrepreneurial idea market. There will be 5 persons employed at the following positions: Pharmacist Master, Technologist; Pharmacist; Organizer, production; Machine operator, pharmaceutical products - two people. 1.4. Rental of a working space on the territory of the town of Troyan, where the production process will take place. 1.5. Outside services for: - Development of technical and financial evaluation of manufactured medicinal products - Development of market analyzes and marketing plans for market realization of the entrepreneurial idea - Creating a candidate's website 2. Project visualization activity, the purpose of which is to promote the produced product and to disclose the contribution of the funding program. Expected results from the realization of the entrepreneurial idea: 1. Developing competitive and efficient production in one of the priority sectors of the economy. 2. Creating opportunities for economic growth and sustainable employment by imposing a new product in the market niche in which the project will be implemented. 3. Imposing effective production processes to help reduce environmental impacts. Increasing the use of generic medicines and the launch of new generic products on the European market is of paramount importance in improving treatment options and expanding patients' access to the necessary medicines.

Comments
Leave a comment

Overview

Status Closed (completion date)
Start date 28 Aug, 2019
End date 01 May, 2021
Contract date 28 Aug, 2019
View in UMIS

Financial information

Total cost 242,989.73
Grant 194,391.79
Self finance 48,597.94
Total paid 0.00
EU participation percent 85.0%

Location